FI890123L - Menetelmä valmistaa terapeuttisesti vaikuttavia indolyylipiperidiiniyhdisteitä - Google Patents

Menetelmä valmistaa terapeuttisesti vaikuttavia indolyylipiperidiiniyhdisteitä Download PDF

Info

Publication number
FI890123L
FI890123L FI890123A FI890123A FI890123L FI 890123 L FI890123 L FI 890123L FI 890123 A FI890123 A FI 890123A FI 890123 A FI890123 A FI 890123A FI 890123 L FI890123 L FI 890123L
Authority
FI
Finland
Prior art keywords
therapeutically active
preparing therapeutically
indolylpiperidine compounds
indolylpiperidine
compounds
Prior art date
Application number
FI890123A
Other languages
English (en)
Swedish (sv)
Other versions
FI91863B (fi
FI91863C (fi
FI890123A0 (fi
Inventor
Masaaki Matsuo
Takashi Manabe
Shinji Shigenaga
Hiroshi Matsuda
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888800795A external-priority patent/GB8800795D0/en
Priority claimed from GB888818260A external-priority patent/GB8818260D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI890123A0 publication Critical patent/FI890123A0/fi
Publication of FI890123L publication Critical patent/FI890123L/fi
Publication of FI91863B publication Critical patent/FI91863B/fi
Application granted granted Critical
Publication of FI91863C publication Critical patent/FI91863C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI890123A 1988-01-14 1989-01-11 Menetelmä valmistaa terapeuttisesti vaikuttavia indolyylipiperidiiniyhdisteitä FI91863C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888800795A GB8800795D0 (en) 1988-01-14 1988-01-14 New indolylpiperidine compounds processes for preparations thereof & pharmaceutical composition comprising same
GB8800795 1988-01-14
GB888818260A GB8818260D0 (en) 1988-08-01 1988-08-01 New indolylpiperidine compounds processes for preparation thereof & pharmaceutical composition comprising same
GB8818260 1988-08-01

Publications (4)

Publication Number Publication Date
FI890123A0 FI890123A0 (fi) 1989-01-11
FI890123L true FI890123L (fi) 1989-07-15
FI91863B FI91863B (fi) 1994-05-13
FI91863C FI91863C (fi) 1994-08-25

Family

ID=26293316

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890123A FI91863C (fi) 1988-01-14 1989-01-11 Menetelmä valmistaa terapeuttisesti vaikuttavia indolyylipiperidiiniyhdisteitä

Country Status (16)

Country Link
US (2) US4935432A (fi)
EP (1) EP0324431B1 (fi)
JP (1) JPH0759577B2 (fi)
KR (1) KR0130899B1 (fi)
CN (1) CN1021733C (fi)
AU (1) AU620583B2 (fi)
CA (1) CA1336605C (fi)
DE (1) DE68901039D1 (fi)
DK (1) DK733788A (fi)
ES (1) ES2032339T3 (fi)
FI (1) FI91863C (fi)
GR (1) GR3004987T3 (fi)
HU (2) HU202224B (fi)
IE (1) IE63476B1 (fi)
IL (1) IL88903A (fi)
NO (1) NO172539C (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
CN1184425A (zh) * 1995-03-20 1998-06-10 伊莱利利公司 5-取代-3-(1,2,3,6-四氢吡啶-4-基)-和3-(哌啶-4-基)-1h-吲哚:新型5-ht1f激动剂
US6458806B1 (en) * 1996-08-15 2002-10-01 Millennium Pharmaceuticals, Inc. Aryl alkenamides derivatives as MCP-1 antagonists
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
CA2341542A1 (en) * 1999-06-24 2000-12-28 Toray Industries, Inc. .alpha.1b-adrenergic receptor antagonists
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
US6803362B2 (en) 2001-03-09 2004-10-12 Ortho-Mcneil Pharmaceutical Inc. Heterocyclic compounds
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
AU2003274956A1 (en) * 2002-09-06 2004-03-29 Janssen Pharmaceutica, N.V. Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis
PL377087A1 (pl) 2002-09-06 2006-01-23 Janssen Pharmaceutica, N.V. Związki heterocykliczne

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2193584B1 (fi) * 1972-07-28 1975-08-08 Roussel Uclaf
GB1425354A (en) * 1973-10-10 1976-02-18 Wyeth John & Brother Ltd Indole derivatives
FR2258843B1 (fi) * 1974-01-30 1977-09-09 Roussel Uclaf
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2349331A1 (fr) * 1976-04-30 1977-11-25 Roussel Uclaf Nouveaux derives de 2,3 dihydro a/4-(3-indolyl) 1-piperidinyl/methyl 1,4-benzodioxin-2-methanol, un procede pour leur preparation et leur application comme medicaments
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
JPS57188567A (en) * 1981-05-13 1982-11-19 Fujimoto Seiyaku Kk Novel preparation of etomidoline
US4443461A (en) * 1981-09-10 1984-04-17 John Wyeth & Brother Limited N-[2-[[1-[1H-Indolylalkyl- or oxoalkyl]-4-piperidinyl]-amino]-2-oxoethyl]-arylcarboxamide derivatives
FR2533924A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant
JPS60142981A (ja) * 1983-12-28 1985-07-29 Yoshitomi Pharmaceut Ind Ltd 3−インド−ルカルボキサミド誘導体
US4673684A (en) * 1984-04-04 1987-06-16 Terumo Corporation Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient
US4548939A (en) * 1984-10-01 1985-10-22 Janssen Pharmaceutica N. V. 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4742057A (en) * 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8903036D0 (en) * 1989-02-10 1989-03-30 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
GR3004987T3 (fi) 1993-04-28
HU211485A9 (en) 1995-11-28
HUT49871A (en) 1989-11-28
US5017703A (en) 1991-05-21
IL88903A (en) 1993-03-15
EP0324431A1 (en) 1989-07-19
IE890048L (en) 1989-07-14
IL88903A0 (en) 1989-08-15
EP0324431B1 (en) 1992-03-25
NO890155D0 (no) 1989-01-13
US4935432A (en) 1990-06-19
KR0130899B1 (ko) 1998-04-23
NO172539B (no) 1993-04-26
HU202224B (en) 1991-02-28
CA1336605C (en) 1995-08-08
ES2032339T3 (es) 1993-02-01
CN1035112A (zh) 1989-08-30
DE68901039D1 (de) 1992-04-30
DK733788D0 (da) 1988-12-30
JPH0759577B2 (ja) 1995-06-28
DK733788A (da) 1989-07-15
FI91863B (fi) 1994-05-13
AU2837089A (en) 1989-07-20
CN1021733C (zh) 1993-08-04
FI91863C (fi) 1994-08-25
JPH01221377A (ja) 1989-09-04
NO890155L (no) 1989-07-17
AU620583B2 (en) 1992-02-20
KR890011872A (ko) 1989-08-23
FI890123A0 (fi) 1989-01-11
NO172539C (no) 1993-08-04
IE63476B1 (en) 1995-04-19

Similar Documents

Publication Publication Date Title
FI870903L (fi) Menetelmä terapeuttisesti aktiivisten alfa-heterosykleillä substituoitujen tolunitriilien valmistamiseksi
FI883050L (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI890652A7 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI893433A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI906204L (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
FI860484L (fi) Menetelmä terapeuttisesti aktiivisten peptidijohdannaisten valmistamiseksi
FI883064A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI892497L (fi) Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi
FI872785A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
IS1667B (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkumbis-aza-bísýklískum efnasamböndum
FI890842A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten stilbeenijohdannaisten valmistamiseksi
FI842760A7 (fi) Menetelmä terapeuttisesti aktiivisten imidatsoliumyhdisteiden valmistamiseksi
FI880869A7 (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
FI882030A7 (fi) Menetelmä terapeuttisesti aktiivisten polysyklisten heterosyklisten yhdisteiden valmistamiseksi
FI890123L (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia indolyylipiperidiiniyhdisteitä
FI890283A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 25-hydroksi-vitamiinin D-johdannaisten valmistamiseksi
FI884471A7 (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI893936A7 (fi) Menetelmä terapeuttisesti aktiivisten yhdisteiden valmistamiseksi sekä välituotteita
FI892185L (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
FI924642L (fi) Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
FI916058A7 (fi) Menetelmä terapeuttisesti aktiivisten dihydrobentsofuraanikarboksamidien valmistamiseksi
FI884660L (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
FI893003L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI874789L (fi) Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.